Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk Factors for Adhesive Small Bowel Obstruction After Liver Cancer Surgery.
Yukawa N, Yamada T, Ichikawa D, Aoyama T, Kataoka K, Shioya T, Tamura T, Shimoyama R, Fukazawa A, Kumamoto K, Yamashita N, Hasegawa S, Saito S, Takemasa I, Fujita F, Taniai N, Kaibori M, Yoshida H. Yukawa N, et al. Among authors: fukazawa a. Cancer Diagn Progn. 2024 Nov 3;4(6):689-695. doi: 10.21873/cdp.10383. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502609 Free PMC article.
A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study).
Yoshida Y, Yamada T, Matsuoka H, Sonoda H, Fukazawa A, Yoshida H, Ishida H, Hirata K, Hasegawa S, Sakamoto K, Otsuka T, Koda K. Yoshida Y, et al. Among authors: fukazawa a. J Anus Rectum Colon. 2019 Jul 30;3(3):136-141. doi: 10.23922/jarc.2018-043. eCollection 2019. J Anus Rectum Colon. 2019. PMID: 31583329 Free PMC article.
The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab.
Kuramochi H, Yamada T, Yoshida Y, Matsuda A, Kamiyama H, Kosugi C, Ishibashi K, Fukazawa A, Ihara K, Sonoda H, Yoshimatsu K, Yoshida H, Hasegawa S, Sakamoto K, Ishida H, Koda K; TAS CC3 Study Group. Kuramochi H, et al. Among authors: fukazawa a. Anticancer Res. 2021 Jun;41(6):3131-3137. doi: 10.21873/anticanres.15098. Anticancer Res. 2021. PMID: 34083307
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study.
Yoshida Y, Yamada T, Kamiyama H, Kosugi C, Ishibashi K, Yoshida H, Ishida H, Yamaguchi S, Kuramochi H, Fukazawa A, Sonoda H, Yoshimatsu K, Matsuda A, Hasegawa S, Sakamoto K, Otsuka T, Koda K; TAS CC3 Study Group.. Yoshida Y, et al. Among authors: fukazawa a. Int J Clin Oncol. 2021 Jan;26(1):111-117. doi: 10.1007/s10147-020-01794-8. Epub 2020 Oct 21. Int J Clin Oncol. 2021. PMID: 33083913 Clinical Trial.
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Matsuoka H, Yamada T, Ohta R, Yoshida Y, Watanabe T, Takahashi M, Kosugi C, Fukazawa A, Kuramochi H, Matsuda A, Sonoda H, Yoshida H, Hasegawa S, Sakamoto K, Otsuka T, Hirata K, Koda K; TAS CC4 Study Group. Matsuoka H, et al. Among authors: fukazawa a. Int J Clin Oncol. 2022 Dec;27(12):1859-1866. doi: 10.1007/s10147-022-02243-4. Epub 2022 Oct 6. Int J Clin Oncol. 2022. PMID: 36201089 Clinical Trial.
[Gallbladder carcinosarcoma associated with pancreaticobiliary maljunction with biliary dilation:a case report].
Watahiki M, Kaneko J, Kiuchi R, Suzuki D, Kosugi T, Kusama D, Tamakoshi H, Niwa T, Takinami M, Tsuji A, Nishino M, Takahashi Y, Jindo O, Fukazawa A, Sasada Y, Yamada T, Sakaguchi T. Watahiki M, et al. Among authors: fukazawa a. Nihon Shokakibyo Gakkai Zasshi. 2024;121(6):505-513. doi: 10.11405/nisshoshi.121.505. Nihon Shokakibyo Gakkai Zasshi. 2024. PMID: 38853020 Japanese.
Comparison of operative outcomes between monopolar and bipolar coagulation in hepatectomy: a propensity score-matched analysis in a single center.
Muraki R, Morita Y, Ida S, Kitajima R, Furuhashi S, Takeda M, Kikuchi H, Hiramatsu Y, Fukazawa A, Sakaguchi T, Fukushima M, Okada E, Takeuchi H. Muraki R, et al. Among authors: fukazawa a. BMC Gastroenterol. 2022 Mar 29;22(1):154. doi: 10.1186/s12876-022-02231-y. BMC Gastroenterol. 2022. PMID: 35351001 Free PMC article.
121 results